Literature DB >> 36034008

An internet-based cross-sectional study on infection control practices and drug use for COVID-19 prevention in Nigerian adults.

Adedoyin Oyeyimika Ogunyemi1, Adedunni Wumi Olusanya2, Adesina Paul Arikawe3, Oluwarotimi Bolaji Olopade4, Uyiekpen Ima-Edomwonyi4, Roland Oluwapelumi Ojo5.   

Abstract

Introduction: COVID-19 has affected several millions of people globally and various means have been employed to curb the spread. This nationwide survey investigated adherence to infection control protocols and drug uptake among Nigerian adults.
Methods: this was a descriptive cross-sectional survey using an internet-based questionnaire to investigate adherence to infection control practices and drug use among adults, who have been resident in Nigeria for at least 6 months. The data was analyzed using Stata software version 16 with levels of significance at p<0.05.
Results: a total of 1235 adults participated in the study. The respondents were aged 18-78 years with a mean age of 36.3 ±11.1 years. Over half (53.0%) of the participants were between 31-50 years. The male to female ratio was 1: 1.45. Majority (92.6%) had a minimum of tertiary educational qualification. One hundred (27.1%) reported a positive test result for COVID-19. A total of 1,204 (97.5%) admitted to wearing of face masks, 1,125 (91.1%) washed hands regularly, 1,142 (92.5%) used hand sanitizers while physical distancing was maintained in 985 (79.8%). A total of 854 (69.2%) were on at least a drug or herbal based therapy. Herbal based remedies were used in 112 (9.1%), supplements in 763 (61.8%), antibiotics in 210 (17%), ivermectin in 205 (16.6%), and antimalarials in 128 (10.4%) participants.
Conclusion: adherence to behavioural measures was high among the population, with widespread uptake of supplements, antibiotics, and antimalarial drugs. The high uptake of antibiotics emphasizes the need to step up regulatory policies for antibiotic use. Copyright: Adedoyin Oyeyimika Ogunyemi et al.

Entities:  

Keywords:  COVID-19; Ivermectin; Nigeria; anti-bacterial agents; antimalarials; infection control; masks; pharmaceutical preparations; plant preparations

Mesh:

Substances:

Year:  2022        PMID: 36034008      PMCID: PMC9379443          DOI: 10.11604/pamj.2022.42.85.31596

Source DB:  PubMed          Journal:  Pan Afr Med J


  37 in total

Review 1.  Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19.

Authors:  Muhammad Torequl Islam; Cristina Quispe; Miquel Martorell; Anca Oana Docea; Bahare Salehi; Daniela Calina; Željko Reiner; Javad Sharifi-Rad
Journal:  Int J Vitam Nutr Res       Date:  2021-01-13       Impact factor: 1.784

2.  Pattern of health care utilization and traditional and complementary medicine use among Ebola survivors in Sierra Leone.

Authors:  Peter Bai James; Jon Wardle; Amie Steel; Jon Adams
Journal:  PLoS One       Date:  2019-09-27       Impact factor: 3.240

3.  A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

Authors:  David R Boulware; Matthew F Pullen; Ananta S Bangdiwala; Katelyn A Pastick; Sarah M Lofgren; Elizabeth C Okafor; Caleb P Skipper; Alanna A Nascene; Melanie R Nicol; Mahsa Abassi; Nicole W Engen; Matthew P Cheng; Derek LaBar; Sylvain A Lother; Lauren J MacKenzie; Glen Drobot; Nicole Marten; Ryan Zarychanski; Lauren E Kelly; Ilan S Schwartz; Emily G McDonald; Radha Rajasingham; Todd C Lee; Kathy H Hullsiek
Journal:  N Engl J Med       Date:  2020-06-03       Impact factor: 91.245

4.  Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.

Authors:  Calistus N Ngonghala; Enahoro Iboi; Steffen Eikenberry; Matthew Scotch; Chandini Raina MacIntyre; Matthew H Bonds; Abba B Gumel
Journal:  Math Biosci       Date:  2020-05-01       Impact factor: 2.144

5.  Thermal inactivation of SARS COVID-2 virus: Are steam inhalations a potential treatment?

Authors:  Giancarlo la Marca; Jacopo Barp; Stefano Frenos; Alessandro Mugelli; Luisa Galli; Elisa Calistri; Giacomo Biasucci; Salvatore De Masi; Renzo Guerrini
Journal:  Life Sci       Date:  2020-11-21       Impact factor: 5.037

6.  Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review.

Authors:  Subhrojyoti Bhowmick; Amit Dang; B N Vallish; Sumit Dang
Journal:  Drug Saf       Date:  2021-04-16       Impact factor: 5.606

7.  The Impact of Universal Mask Use on SARS-COV-2 in Victoria, Australia on the Epidemic Trajectory of COVID-19.

Authors:  Valentina Costantino; Chandini Raina MacIntyre
Journal:  Front Public Health       Date:  2021-04-21

8.  Use of Antimicrobials among Suspected COVID-19 Patients at Selected Hospitals, Bangladesh: Findings from the First Wave of COVID-19 Pandemic.

Authors:  Syeda Mah-E-Muneer; Md Zakiul Hassan; Md Abdullah Al Jubayer Biswas; Fahmida Rahman; Zubair Akhtar; Pritimoy Das; Md Ariful Islam; Fahmida Chowdhury
Journal:  Antibiotics (Basel)       Date:  2021-06-18

9.  Barriers and facilitators of adherence to social distancing recommendations during COVID-19 among a large international sample of adults.

Authors:  Adina Coroiu; Chelsea Moran; Tavis Campbell; Alan C Geller
Journal:  PLoS One       Date:  2020-10-07       Impact factor: 3.240

10.  Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19.

Authors:  Elisa Baranski Lamback; Monica Amorim de Oliveira; Andrea Ferreira Haddad; André Filipe Marcondes Vieira; Armando Leão Ferreira Neto; Taciana da Silva Maia; Juliana de Rezende Chrisman; Pedro Pimenta de Mello Spineti; Marco Antonio de Mattos; Eduardo Costa
Journal:  Braz J Infect Dis       Date:  2021-02-19       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.